KING & SPAULDING ADDS TWO REGULATORY SPECIALISTS FOR DEVICE ISSUES TO ITS ROSTER

International law firm King & Spaulding is expanding its FDA and healthcare practice with the addition of two experts on regulatory issues affecting the device industry, the firm announced July 24.

Beverly Lorell is a former member of the FDA's cardiovascular and renal drugs advisory committee and recently stepped down as vice president and chief medical and technology officer at Guidant, King & Spaulding noted. She will specialize in the clinical trial design, review of premarket submissions, recalls and the health risk assessments, the firm said.

Attorney M. Kay Scanlan will specialize in biotechnology reimbursement consulting. She has taught Medicare and Medicaid law at the University of Maryland, served in the Office of General Counsel for the Centers for Medicare & Medicaid Services and was a director of reimbursement strategy at Biogen Idec.